A Doctor of Pharmacy and accomplished pharmaceutical executive with an entrepreneurial spirit. Extensive hands-on and management experience in Clinical Research, Pharmacovigilance and Strategic Planning. Innovative clinical and regulatory strategist with proven ability for NDA approvals. Effective leader that uses respect and a “lead-by-example” approach to achieve objectives. Key accomplishments include: 9 successful NDAs, including products with Orphan Drug and Fast Tract Approval designations; design and operation of a Phase 1 clinical pharmacology center in Ireland; initiation/supervision of Clinical Research Departments at two companies; cordinator and/or investigator for over 30 clinical trials; key project manager in the integration of US and international pharmacovigilance programs; directed the selection and management of pharmacovigilance database; responsible for FDA pre- and postmarketing reporting of adverse drug reactions at 2 companies. Author of over 20 publications, 30 abstracts and 2 book chapters. Specialties: Pharmacovigilance and REMS, medical writing, clinical protocol development and execution, NDA clinical preparation/review, clinical & safety due diligence inspections, bioequivalence studies, SOP development, GCP.
Listed skills include Clinical Trials, Clinical Development, Pharmaceutical Industry, Pharmacovigilance, and 21 others.